Dopamine inhibits human CD8+ Treg function through D 1 -like dopaminergic receptors

Giorgia Nasi, Tanzeel Ahmed, Emanuela Rasini, Daniela Fenoglio, Franca Marino, Gilberto Filaci, Marco Cosentino

Research output: Contribution to journalArticle

Abstract

CD8+ T regulatory/suppressor cells (Treg) affect peripheral tolerance and may be involved in autoimmune diseases as well as in cancer. In view of our previous data showing the ability of DA to affect adaptive immune responses, we investigated the dopaminergic phenotype of human CD8+ Treg as well as the ability of DA to affect their generation and activity. Results show that CD8+ T cells express both D 1 -like and D 2 -like dopaminergic receptors (DR), tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthesis of DA, and vesicular monoamine transporter (VMAT) 2 and contain high levels of intracellular DA. Preferential upregulation of DR mRNA levels in the CD8+CD28- T cell compartment occurs during generation of CD8+ Treg, which is reduced by DA and by the D 1 -like DR agonist SKF-38393. DA and SKF-38393 also reduce the suppressive activity of CD8+ Treg on human peripheral blood mononuclear cells. Treg are crucial for tumor escape from the host immune system, thus the ability of DA to inhibits Treg function supports dopaminergic pathways as a druggable targets to develop original and innovative antitumor strategies.

Original languageEnglish
JournalJournal of Neuroimmunology
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Regulatory T-Lymphocytes
Dopamine
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
Vesicular Monoamine Transport Proteins
Tumor Escape
Peripheral Tolerance
T-Lymphocytes
Dopamine Agonists
Tyrosine 3-Monooxygenase
Adaptive Immunity
Autoimmune Diseases
Immune System
Blood Cells
Up-Regulation
Phenotype
Messenger RNA
Enzymes
Neoplasms

Keywords

  • CD8+ Treg
  • Dopamine
  • Dopaminergic receptor

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Cite this

Dopamine inhibits human CD8+ Treg function through D 1 -like dopaminergic receptors. / Nasi, Giorgia; Ahmed, Tanzeel; Rasini, Emanuela; Fenoglio, Daniela; Marino, Franca; Filaci, Gilberto; Cosentino, Marco.

In: Journal of Neuroimmunology, 01.01.2019.

Research output: Contribution to journalArticle

Nasi, Giorgia ; Ahmed, Tanzeel ; Rasini, Emanuela ; Fenoglio, Daniela ; Marino, Franca ; Filaci, Gilberto ; Cosentino, Marco. / Dopamine inhibits human CD8+ Treg function through D 1 -like dopaminergic receptors. In: Journal of Neuroimmunology. 2019.
@article{1fc0743a009b4807963cdcdb1d458619,
title = "Dopamine inhibits human CD8+ Treg function through D 1 -like dopaminergic receptors",
abstract = "CD8+ T regulatory/suppressor cells (Treg) affect peripheral tolerance and may be involved in autoimmune diseases as well as in cancer. In view of our previous data showing the ability of DA to affect adaptive immune responses, we investigated the dopaminergic phenotype of human CD8+ Treg as well as the ability of DA to affect their generation and activity. Results show that CD8+ T cells express both D 1 -like and D 2 -like dopaminergic receptors (DR), tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthesis of DA, and vesicular monoamine transporter (VMAT) 2 and contain high levels of intracellular DA. Preferential upregulation of DR mRNA levels in the CD8+CD28- T cell compartment occurs during generation of CD8+ Treg, which is reduced by DA and by the D 1 -like DR agonist SKF-38393. DA and SKF-38393 also reduce the suppressive activity of CD8+ Treg on human peripheral blood mononuclear cells. Treg are crucial for tumor escape from the host immune system, thus the ability of DA to inhibits Treg function supports dopaminergic pathways as a druggable targets to develop original and innovative antitumor strategies.",
keywords = "CD8+ Treg, Dopamine, Dopaminergic receptor",
author = "Giorgia Nasi and Tanzeel Ahmed and Emanuela Rasini and Daniela Fenoglio and Franca Marino and Gilberto Filaci and Marco Cosentino",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jneuroim.2019.02.007",
language = "English",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier Science B.V.",

}

TY - JOUR

T1 - Dopamine inhibits human CD8+ Treg function through D 1 -like dopaminergic receptors

AU - Nasi, Giorgia

AU - Ahmed, Tanzeel

AU - Rasini, Emanuela

AU - Fenoglio, Daniela

AU - Marino, Franca

AU - Filaci, Gilberto

AU - Cosentino, Marco

PY - 2019/1/1

Y1 - 2019/1/1

N2 - CD8+ T regulatory/suppressor cells (Treg) affect peripheral tolerance and may be involved in autoimmune diseases as well as in cancer. In view of our previous data showing the ability of DA to affect adaptive immune responses, we investigated the dopaminergic phenotype of human CD8+ Treg as well as the ability of DA to affect their generation and activity. Results show that CD8+ T cells express both D 1 -like and D 2 -like dopaminergic receptors (DR), tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthesis of DA, and vesicular monoamine transporter (VMAT) 2 and contain high levels of intracellular DA. Preferential upregulation of DR mRNA levels in the CD8+CD28- T cell compartment occurs during generation of CD8+ Treg, which is reduced by DA and by the D 1 -like DR agonist SKF-38393. DA and SKF-38393 also reduce the suppressive activity of CD8+ Treg on human peripheral blood mononuclear cells. Treg are crucial for tumor escape from the host immune system, thus the ability of DA to inhibits Treg function supports dopaminergic pathways as a druggable targets to develop original and innovative antitumor strategies.

AB - CD8+ T regulatory/suppressor cells (Treg) affect peripheral tolerance and may be involved in autoimmune diseases as well as in cancer. In view of our previous data showing the ability of DA to affect adaptive immune responses, we investigated the dopaminergic phenotype of human CD8+ Treg as well as the ability of DA to affect their generation and activity. Results show that CD8+ T cells express both D 1 -like and D 2 -like dopaminergic receptors (DR), tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthesis of DA, and vesicular monoamine transporter (VMAT) 2 and contain high levels of intracellular DA. Preferential upregulation of DR mRNA levels in the CD8+CD28- T cell compartment occurs during generation of CD8+ Treg, which is reduced by DA and by the D 1 -like DR agonist SKF-38393. DA and SKF-38393 also reduce the suppressive activity of CD8+ Treg on human peripheral blood mononuclear cells. Treg are crucial for tumor escape from the host immune system, thus the ability of DA to inhibits Treg function supports dopaminergic pathways as a druggable targets to develop original and innovative antitumor strategies.

KW - CD8+ Treg

KW - Dopamine

KW - Dopaminergic receptor

UR - http://www.scopus.com/inward/record.url?scp=85063758013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063758013&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2019.02.007

DO - 10.1016/j.jneuroim.2019.02.007

M3 - Article

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

ER -